Kyle Stansifer, MD
Otolaryngology · Omaha, NENPI 1962766600
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,434 of the $3,442 with a category attached, or 70.7%. Aerin Medical Inc. accounts for 75.7% of it on its own, with 9 other manufacturers making up the rest. 2025 is the largest year on record at $2,082, more than ten times the $174 reported in 2019. Among otolaryngology clinicians in NE with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 47 payments — averaging $73.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Aerin Medical Inc.$3K
- Medtronic$321
- Optinose US, Inc.$141
- Intersect ENT, Inc.$141
- Stryker$61
- Neurent Medical Limited$56
- plus $116 from 4 others
What the payments were for
- Travel & lodging$1,00829%
- Food & beverage$2,43471%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Aerin Medical Inc. | 24 | $2,605 |
| Medtronic | 4 | $321 |
| Optinose US, Inc. | 7 | $141 |
| Intersect ENT, Inc. | 1 | $141 |
| Stryker | 3 | $61 |
| Neurent Medical Limited | 2 | $56 |
| Acclarent, Inc | 3 | $51 |
| Sanofi | 1 | $23 |
| Amgen | 1 | $22 |
| Smith+Nephew | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VIVAER STYLUS$1,995
- RHINAER STYLUS$662
- PROPEL$331
How this compares
$3,442 in reported general payments places this provider in the 90th percentile of 86 otolaryngology providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 103 | $2,548 |
| Fluticasone Propionate | 43 | $548 |
| Azelastine Hcl | 24 | $504 |
| Dexamethasone Sodium Phosphate | 13 | $480 |
| Doxycycline Monohydrate | 19 | $476 |
| Cefdinir | 14 | $407 |
| Ofloxacin | 14 | $239 |
| Fluconazole | 16 | $196 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 14 | $147 |
| Mupirocin | 23 | $133 |
| Prednisone | 19 | $30 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Omaha
- Rahul VarmanOmaha$13K
- Daniel O'BrienOmaha$10K
- Wallace DuffOmaha$8K
- Tyler BlissOmaha$4K
- Adam PleasOmaha$4K
- Jessica Moran-HansenOmaha$3K
- Jason TalmadgeOmaha$3K
- Thomas DoblemanOmaha$3K
- Stanley SchackOmaha$3K
- Paul SherrerdOmaha$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.